ATC: A05AA02
Therapeutic Area: Alimentary tract and metabolism
Therapeutic Indications: Biliary therapy
50 caps 250 mg / Shelf: 36 months
50 caps 500 mg / Shelf: 36 months
30 tabs 300 mg / Shelf: 36 months
tabs 450 mg prompt release / Shelf: 36 months